Extensive CArdioVAscular Characterization and Follow-Up of Patients Receiving Immune Checkpoint Inhibitors: A Prospective Multicenter Study.

Danielle DelombaerdeJohan De SutterLieselot CroesDelphine VervloetVeronique MoermanNico Van de VeireAnne-Marie WillemsKristien WoutersMarc PeetersHans Prenen Christof Vulsteke

Published in: Pharmaceuticals (Basel, Switzerland) (2023)

ClinicalTrials.gov Identifier: NCT05699915, registered 26 January 2023.

Keyphrases